Recursion Pharmaceuticals Inc Clas (RXRX)
SG&A Expense Growth
-0.90%
Fiscal year · Period ending:
RXRX SG&A Expense Growth
Latest reported-0.90%period ending
Latest reported-0.90%period ending
RXRX FY SG&A Growth (YoY) (0.00% → -0.90%)
Latest values, visible window
High-resolution chart · PNG
RXRX sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -0.8951% | |
| 60.784% | |
| 35.8129% | |
| 41.4635% | |
| 128.3712% | |
| 33.2806% | |
| 0% |